BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15694273)

  • 1. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.
    Benedetti F; Serretti A; Pontiggia A; Bernasconi A; Lorenzi C; Colombo C; Smeraldi E
    Neurosci Lett; 2005 Mar; 376(1):51-5. PubMed ID: 15694273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.
    Benedetti F; Serretti A; Colombo C; Lorenzi C; Tubazio V; Smeraldi E
    Neurosci Lett; 2004 Sep; 368(2):123-6. PubMed ID: 15351432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder.
    Benedetti F; Bernasconi A; Lorenzi C; Pontiggia A; Serretti A; Colombo C; Smeraldi E
    Neurosci Lett; 2004 Jan; 355(1-2):37-40. PubMed ID: 14729229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
    Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-gene interaction of glycogen synthase kinase 3-β and serotonin transporter on human antidepressant response to sleep deprivation.
    Benedetti F; Dallaspezia S; Lorenzi C; Pirovano A; Radaelli D; Locatelli C; Poletti S; Colombo C; Smeraldi E
    J Affect Disord; 2012 Feb; 136(3):514-9. PubMed ID: 22119086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium.
    Lin YF; Huang MC; Liu HC
    J Affect Disord; 2013 May; 147(1-3):401-6. PubMed ID: 23021822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism.
    Adli M; Hollinde DL; Stamm T; Wiethoff K; Tsahuridu M; Kirchheiner J; Heinz A; Bauer M
    Biol Psychiatry; 2007 Dec; 62(11):1295-302. PubMed ID: 17628506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
    Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
    World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype analysis of GSK-3β gene polymorphisms in bipolar disorder lithium responders and nonresponders.
    Iwahashi K; Nishizawa D; Narita S; Numajiri M; Murayama O; Yoshihara E; Onozawa Y; Nagahori K; Fukamauchi F; Ikeda K; Ishigooka J
    Clin Neuropharmacol; 2014; 37(4):108-10. PubMed ID: 24992082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder.
    Benedetti F; Bollettini I; Barberi I; Radaelli D; Poletti S; Locatelli C; Pirovano A; Lorenzi C; Falini A; Colombo C; Smeraldi E
    Neuropsychopharmacology; 2013 Jan; 38(2):313-27. PubMed ID: 22990942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes.
    Mitjans M; Arias B; Jiménez E; Goikolea JM; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
    J Clin Psychopharmacol; 2015 Oct; 35(5):600-4. PubMed ID: 26267417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between GSK3β gene and increased impulsivity in bipolar disorder.
    Jiménez E; Arias B; Mitjans M; Goikolea JM; Roda E; Ruíz V; Pérez A; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Vieta E; Benabarre A
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):510-8. PubMed ID: 24486183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder.
    Dallaspezia S; Poletti S; Lorenzi C; Pirovano A; Colombo C; Benedetti F
    Mol Diagn Ther; 2012 Oct; 16(5):303-9. PubMed ID: 23023733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression.
    Saus E; Soria V; Escaramís G; Crespo JM; Valero J; Gutiérrez-Zotes A; Martorell L; Vilella E; Menchón JM; Estivill X; Gratacòs M; Urretavizcaya M
    Genes Brain Behav; 2010 Oct; 9(7):799-807. PubMed ID: 20618448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
    Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
    Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders.
    Serretti A; Benedetti F; Mandelli L; Calati R; Caneva B; Lorenzi C; Fontana V; Colombo C; Smeraldi E
    Psychiatry Res; 2008 Mar; 158(2):132-40. PubMed ID: 17976739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients.
    Lee YJ; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1303-8. PubMed ID: 21549170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of circadian clock genes and prophylactic lithium response.
    Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
    Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3.
    Gould TD; Chen G; Manji HK
    Neuropsychopharmacology; 2004 Jan; 29(1):32-8. PubMed ID: 12942141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the Association between Lithium Treatment and GSK3β Polymorphism in Bipolar Disorder Patients].
    Altınbaş K; Yeşilbaş D; İnce B; Cansız A; Sılan F; Özdemir Ö; Gülöksüz S
    Turk Psikiyatri Derg; 2018; 29(2):73-78. PubMed ID: 30215834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.